Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2017

View Archived Issues

Pan-CK2 inhibitor BMS-159 chosen for development as anticancer candidate

IdeS reduces donor-specific antibodies allowing for HLA-incompatible transplantation

Genentech presents data from phase I trial of influenza B candidate MHAB-5553A

BMP inhibition a novel pharmacological strategy for multiple hereditary exostoses

Trisubstituted benzene CGRP antagonists for migraine created at Merck & Co.

PharmAkea completes phase I study of PAT-1251

New phase IIa trial tests S. hominis lotion for atopic dermatitis

Sun Pharma Advanced Research discovers novel Bruton tyrosine kinase inhibitors

Pharmakea presents new lysyl oxidase homolog 2 inhibitors

Takeda submits Japanese NDA for vedolizumab for ulcerative colitis

FDA grants orphan drug designation to Jotrol for Friedreich's ataxia

CIRM grant supports Cellerant's development of CLT030-ADC for AML

Phase Ib results reported for proinsulin peptide immunotherapy in subjects with type 1 diabetes

AC Immune expands neurodegenerative pipeline with new antibodies against alpha-synuclein and TDP-43

Topas signs research and option agreement with Lilly focused on antigen-specific tolerance induction

Janssen describes synthesis of GPR40 full agonists for type 2 diabetes

CRISPR Therapeutics and Massachusetts General Hospital collaborate to develop T-cell therapies

Obesity compounds begin phase I trials under Zealand and Boehringer Ingelheim collaboration

Phase III study of Ace-ER in GNE myopathy misses primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...